MedPath

Sera Prognostics

🇺🇸United States
Ownership
-
Employees
57
Market Cap
-
Website
Introduction

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Sera Prognostics to Present at TD Cowen Conference and Report Q1 2025 Results in May

Sera Prognostics, focused on maternal and neonatal health through pregnancy biomarker testing, will present at the TD Cowen 45th Annual Health Care Conference on March 5, 2025, with CEO Zhenya Lindgardt providing company updates.

© Copyright 2025. All Rights Reserved by MedPath